Back to Journals » Breast Cancer: Targets and Therapy » Volume 10
Original Research
![Noteworthy comment: This is an interesting small molecule that restores the function of mutant p53. It might be used with other current drugs for a bigger impact.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,441 | Dovepress* | 10,525+ | 1,401 | 11,926 | |
PubMed Central* | 916 | 218 | 1,134 | ||
Totals | 11,441 | 1,619 | 13,060 | ||
*Since 22 March 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
38 | 1 | 0 | 0 | 6 | 31 |
View citations on PubMed Central and Google Scholar